These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30343377)

  • 41. Patient satisfaction and changes in prolapse and urinary symptoms in women who were fitted successfully with a pessary for pelvic organ prolapse.
    Clemons JL; Aguilar VC; Tillinghast TA; Jackson ND; Myers DL
    Am J Obstet Gynecol; 2004 Apr; 190(4):1025-9. PubMed ID: 15118635
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors associated with unsuccessful pessary fitting in women with symptomatic pelvic organ prolapse: Systematic review and metanalysis.
    de Albuquerque Coelho SC; Brito LGO; de Araujo CC; Juliato CRT
    Neurourol Urodyn; 2020 Sep; 39(7):1912-1921. PubMed ID: 32649024
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation of POP-Q posterior compartment measures with defecatory dysfunction.
    Collins SA; O'Sullivan DM; Lasala CA
    Int Urogynecol J; 2012 Jun; 23(6):743-7. PubMed ID: 22249278
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful use of the Gellhorn pessary as a second-line pessary in women with advanced pelvic organ prolapse.
    Deng M; Ding J; Ai F; Zhu L
    Menopause; 2017 Nov; 24(11):1277-1281. PubMed ID: 28640155
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pessary use and management for pelvic organ prolapse.
    Atnip SD
    Obstet Gynecol Clin North Am; 2009 Sep; 36(3):541-63. PubMed ID: 19932415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of overactive bladder symptoms among women with successful pessary placement.
    Zacharakis D; Grigoriadis T; Pitsouni E; Kypriotis K; Vogiatzis N; Athanasiou S
    Int Urogynecol J; 2018 Apr; 29(4):571-577. PubMed ID: 28871426
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Temporal relationship between posterior vaginal prolapse and defecatory symptoms.
    Handa VL; Muňoz A; Blomquist JL
    Am J Obstet Gynecol; 2017 Apr; 216(4):390.e1-390.e6. PubMed ID: 27780707
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaginal pessary continuation in symptomatic pelvic organ prolapse patients with prior hysterectomy.
    Ma C; Kang J; Xu T; Zhang Y; Ma Y; Liang S; Hui Y; Wang Y; Zhu L
    Menopause; 2020 Oct; 27(10):1148-1154. PubMed ID: 32881830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Continence pessaries in the management of urinary incontinence in women.
    Farrell SA; Singh B; Aldakhil L
    J Obstet Gynaecol Can; 2004 Feb; 26(2):113-7. PubMed ID: 14965476
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Successful use of ring pessary with support for advanced pelvic organ prolapse.
    Ding J; Chen C; Song XC; Zhang L; Deng M; Zhu L
    Int Urogynecol J; 2015 Oct; 26(10):1517-23. PubMed ID: 25982787
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sexual activity predicts continued pessary use.
    Brincat C; Kenton K; Pat Fitzgerald M; Brubaker L
    Am J Obstet Gynecol; 2004 Jul; 191(1):198-200. PubMed ID: 15295365
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Feasibility of using pessaries for treatment of pelvic organ prolapse in rural Nepal.
    Robert M; Govan AJ; Lohani U; Uprety A
    Int J Gynaecol Obstet; 2017 Mar; 136(3):325-330. PubMed ID: 28099682
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patient Satisfaction and Symptoms Improvement in Women Using a Vginal Pessary for The Treatment of Pelvic Organ Prolapse.
    Radnia N; Hajhashemi M; Eftekhar T; Deldar M; Mohajeri T; Sohbati S; Ghanbari Z
    J Med Life; 2019; 12(3):271-275. PubMed ID: 31666830
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Commentary on 'Defecatory dysfunction and other clinical variables are predictors of pessary discontinuation'.
    Abdelrahman A
    Int Urogynecol J; 2019 Jul; 30(7):1117. PubMed ID: 30623209
    [No Abstract]   [Full Text] [Related]  

  • 55. Quality of life in women who use pessaries for longer than 12 months.
    Tenfelde S; Tell D; Thomas TN; Kenton K
    Female Pelvic Med Reconstr Surg; 2015; 21(3):146-9. PubMed ID: 25521465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vaginal pessary treatment in women with symptomatic pelvic organ prolapse: a long-term prospective study.
    Ma C; Zhou Y; Kang J; Zhang Y; Ma Y; Wang Y; Tian W; Xu T; Liang S; Fan G; Cui Y; Zhu L
    Menopause; 2021 Feb; 28(5):538-545. PubMed ID: 33625108
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Translabial ultrasound indices of failed pessary fittings in women with symptomatic pelvic organ prolapse.
    Xu H; Wu W; Wang X; Xia Z
    Menopause; 2022 Jan; 29(4):390-396. PubMed ID: 35357363
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of vaginal estrogen on pessary use.
    Dessie SG; Armstrong K; Modest AM; Hacker MR; Hota LS
    Int Urogynecol J; 2016 Sep; 27(9):1423-9. PubMed ID: 26992727
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term Outcomes of Self-Management Gellhorn Pessary for Symptomatic Pelvic Organ Prolapse.
    Chien CW; Lo TS; Tseng LH; Lin YH; Hsieh WC; Lee SJ
    Female Pelvic Med Reconstr Surg; 2020 Nov; 26(11):e47-e53. PubMed ID: 31393340
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Depressive symptoms affect outcomes of pessary use in postmenopausal women with uterine prolapse.
    Ai FF; Zhu L; Mao M; Zhang Y; Kang J
    Climacteric; 2018 Apr; 21(2):184-188. PubMed ID: 29397780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.